Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Endometrial Neoplasms 8Uterine Cervical Neoplasms 6Leiomyoma 6Ovarian Neoplasms 4Myofibroma 3Uterine Neoplasms 2FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 2Carcinoma, Ovarian Epithelial 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Prolapse 1Uterine Cervical Dysplasia 1Sarcoma 1Precancerous Conditions 1Metrorrhagia 1Menstruation Disturbances 1Menorrhagia 1Hysterectomy 1Hereditary Breast and Ovarian Cancer Syndrome 1Fallopian Tube Neoplasms 1Endometriosis 1Endometrial Hyperplasia 1Disease 1Carcinoma, Squamous Cell 1Carcinoma, Endometrioid 1Carcinoma, Adenosquamous 1Adenomyosis 1Adenocarcinoma 1

Interventions

Paclitaxel 13pembrolizumab 8Carboplatin 7Surveys and Questionnaires 6Cisplatin 6Brachytherapy 5Doxorubicin 4Docetaxel 4Pemetrexed 3Hyperthermic Intraperitoneal Chemotherapy 3Gemcitabine 3FANG vaccine 3Biopsy 3osimertinib 2olaparib 2niraparib 2durvalumab 2adavosertib 2Trastuzumab 2Topotecan 2Taxes 2Standard of Care 2Sentinel Lymph Node Biopsy 2Saline Solution 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiation 2Oxaliplatin 2Nivolumab 2Music Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Uterine Neoplasms × Hysterectomy × Clear all
NCT03694834 2023-11-28

Window of Opportunity Pilot Study of Pembrolizumab in Obesity-driven Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
3 enrolled
Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

NCT00100191 2005-06-24

Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids

ZonMw: The Netherlands Organisation for Health Research and Development

Phase 3 Completed
120 enrolled
Gynecologic

Leiomyoma, Menorrhagia, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡